With SpinUp partner TIAP and speaker Ido Kaminsky.
Webinar Description: In this session, we will discuss the basics of fundraising in the life-sciences space. We’ll consider the different types of investors and how they approach the diligence and investment process, the classes of investment vehicles, best practices and pitfalls in investor outreach and interaction, typical diligence processes, guidelines for successfully negotiating term-sheets, and managing relationships with academic founders pre and post-investment.
* Please note this webinar series is open to members of the University of Toronto, University of Toronto Entrepreneurship (UTE), and IDEA Mississauga communities only.
About TIAP
Toronto Innovation Acceleration Partners (TIAP) specializes in venture building of early-stage health science technologies emerging from our members. TIAP was formerly MaRS Innovation.
TIAP identifies, funds, and develops transformative, member-sourced, early-stage innovation into successful Canadian companies. Our portfolio consists solely of technologies in therapeutics, medical devices and digital health. We develop this portfolio in close consultation with our Members and their inventors to advance the most promising innovations with the greatest potential to make a change for patients. Further development of the portfolio is supported by our deep network of industry advisors and by matched funding from international and local investors.
TIAP is a member-supported, not-for-profit organization created in 2008 to develop innovative research from its Members: Toronto’s top universities, hospitals and research institutes.
Meet the Speaker
Ido Kaminsky is Director of Technology & Venture development with Toronto Innovation Acceleration Partners (TIAP). In his role, Ido supports the spinout of early-stage therapeutic technologies from the Toronto Innovation Ecosystem, as well as investments into existing startups in that space. Previously, Ido served as a Director of BD at FutuRx, an incubator operated by J&J, Takeda, and Orbimed, where he led scouting and evaluation activities resulting in the creation of over 10 biotech startups.
